H-CYTE (OTCMKTS:HCYTD) Shares Down 49.5% – What’s Next?

H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s stock price was down 49.5% on Thursday . The company traded as low as $2.02 and last traded at $2.02. 400 shares were traded during mid-day trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.

H-CYTE Price Performance

The stock has a 50 day moving average of $2.02 and a two-hundred day moving average of $2.02.

About H-CYTE

(Get Free Report)

H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Further Reading

• Five stocks we like better than H-CYTE
• 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
• Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
• Flash in the Pan or Sustained Rally Contender? 3 Momentum Stocks to Watch
• MarketBeat Week in Review – 08/17 – 08/21